These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 16496953)

  • 1. [Lectins, adhesins, and lectin-like substances of lactobacilli and bifidobacteria].
    Lakhtin VM; Aleshkin VA; Lakhtin MV; Afanas'ev SS; Pospelova VV; Shenderov BA
    Vestn Ross Akad Med Nauk; 2006; (1):28-34. PubMed ID: 16496953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Criteria for selection of lactobacilli for probiotic use].
    Nemcová R
    Vet Med (Praha); 1997 Jan; 42(1):19-27. PubMed ID: 9123779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antagonistic activity of probiotic lactobacilli and bifidobacteria against entero- and uropathogens.
    Hütt P; Shchepetova J; Lõivukene K; Kullisaar T; Mikelsaar M
    J Appl Microbiol; 2006 Jun; 100(6):1324-32. PubMed ID: 16696680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adhesion characteristics of lactobacillus is a criterion of the probiotic choice.
    Kravtsov EG; Yermolayev AV; Anokhina IV; Yashina NV; Chesnokova VL; Dalin MV
    Bull Exp Biol Med; 2008 Feb; 145(2):232-4. PubMed ID: 19023977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bifidobacteria and lactobacilli in human health.
    Orrhage K; Nord CE
    Drugs Exp Clin Res; 2000; 26(3):95-111. PubMed ID: 10941602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lactobacilli, bifidobacteria and E. coli nissle induce pro- and anti-inflammatory cytokines in peripheral blood mononuclear cells.
    Helwig U; Lammers KM; Rizzello F; Brigidi P; Rohleder V; Caramelli E; Gionchetti P; Schrezenmeir J; Foelsch UR; Schreiber S; Campieri M
    World J Gastroenterol; 2006 Oct; 12(37):5978-86. PubMed ID: 17009396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunology and probiotic impact of the newborn and young children intestinal microflora.
    Bezirtzoglou E; Stavropoulou E
    Anaerobe; 2011 Dec; 17(6):369-74. PubMed ID: 21515397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Some probiotic properties of chicken lactobacilli.
    Gusils C; González SN; Oliver G
    Can J Microbiol; 1999 Dec; 45(12):981-7. PubMed ID: 10696476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions between the microbiota and the intestinal mucosa.
    Schiffrin EJ; Blum S
    Eur J Clin Nutr; 2002 Aug; 56 Suppl 3():S60-4. PubMed ID: 12142966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effects of six probiotic strains on immune function in vitro.
    Dong H; Rowland I; Yaqoob P
    Br J Nutr; 2012 Aug; 108(3):459-70. PubMed ID: 22054064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Surface properties of Lactobacillus strains. II. Adherence to tissue culture surfaces].
    Strus M; Kukla G; Rurańska-Smutnicka D; Przondo-Mordarska A; Heczko P
    Med Dosw Mikrobiol; 2001; 53(3):253-8. PubMed ID: 11785182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of bioactive substances by intestinal bacteria as a basis for explaining probiotic mechanisms: bacteriocins and conjugated linoleic acid.
    O'Shea EF; Cotter PD; Stanton C; Ross RP; Hill C
    Int J Food Microbiol; 2012 Jan; 152(3):189-205. PubMed ID: 21742394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human intestinal mucosa-associated Lactobacillus and Bifidobacterium strains with probiotic properties modulate IL-10, IL-6 and IL-12 gene expression in THP-1 cells.
    Čitar M; Hacin B; Tompa G; Štempelj M; Rogelj I; Dolinšek J; Narat M; Matijašić BB
    Benef Microbes; 2015; 6(3):325-36. PubMed ID: 25391349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors involved in the colonization and survival of bifidobacteria in the gastrointestinal tract.
    González-Rodríguez I; Ruiz L; Gueimonde M; Margolles A; Sánchez B
    FEMS Microbiol Lett; 2013 Mar; 340(1):1-10. PubMed ID: 23181549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens.
    Servin AL
    FEMS Microbiol Rev; 2004 Oct; 28(4):405-40. PubMed ID: 15374659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific Lactobacillus/Mutans Streptococcus co-aggregation.
    Lang C; Böttner M; Holz C; Veen M; Ryser M; Reindl A; Pompejus M; Tanzer JM
    J Dent Res; 2010 Feb; 89(2):175-9. PubMed ID: 20042742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adhesion of bifidobacteria to granular starch and its implications in probiotic technologies.
    Crittenden R; Laitila A; Forssell P; Mättö J; Saarela M; Mattila-Sandholm T; Myllärinen P
    Appl Environ Microbiol; 2001 Aug; 67(8):3469-75. PubMed ID: 11472921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lectin-like binding of lactobacilli considered for their use in probiotical preparations for animal use.
    Styriak I; Nemcová R
    Berl Munch Tierarztl Wochenschr; 2003; 116(3-4):96-101. PubMed ID: 12680274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of probiotics in the prevention and treatment of meticillin-resistant Staphylococcus aureus infections.
    Sikorska H; Smoragiewicz W
    Int J Antimicrob Agents; 2013 Dec; 42(6):475-81. PubMed ID: 24071026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and characterization of faecal bifidobacteria and lactobacilli isolated from dogs and primates.
    Strompfová V; Lauková A
    Anaerobe; 2014 Oct; 29():108-12. PubMed ID: 24239978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.